Enfermedades infecciosas emergentes

Medicina Clinica

Volumn 109, Issue 14, 1997, Pages 553-561

  Gestal Otero, Juan Jesús ^a,b   Guzmán, Adolfe Figueiras ^a   Martínez, Agustin Montes ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; COMMUNICABLE DISEASE; COMPARATIVE STUDY; DISEASE TRANSMISSION; FEMALE; HEALTH; HUMAN; INFECTION CONTROL; MALE; REVIEW; RISK FACTOR;

ADULT; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; FEMALE; HUMANS; MALE; RISK FACTORS; WORLD HEALTH;

EID: 0031586427     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (125)

1. Soper FL. Rehabilitation of the eradication concept in prevention of communicable diseases. En: Kerr JA, editor. Building the health bridge. Selections from the works of Fred L. Soper. Bloomington: Indiana University Press 1970; 337-354.
2. Rockefeller Foundation. Annual report, including report of the International Health Division. Nueva York: Rockefeller Foundation, 1915.
3. Ministerio de Sanidad. Décimo aniversario de la erradicación de la viruela. Bol Epidemiol Sem 1987; 1793: 265-266.
4. Carreras Panchón A. Miasmas y retrovirus. Cuatro capitulos de la historia de las enfermedades transmisibles. Barcelona: Fundación Uriach 1838, 1992.
5. Fraser DW, Tsai TR, Orenstein W, Parkin WE, Beecham HJ, Sharrar RG et al. Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977; 297: 1.189-1.197.
6. McDade JE, Shepard CC, Fraser DW, Tsai TR, Redus MA, Dowdle WR. Legionnaires' disease: isolation of a bacterium and demostration of its role in other respiratory disease. N Engl J Med 1977; 297: 1.197-1.203.
7. Steere AC, Malawista SE, Snydman, Shope RE, Andiman WA, Ross MR et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7-17.
8. WHO. Lyme disease 1991-1992. United States of America. WER 1993; 68: 273-275.
9. CDC. Summary of notifiable diseases United States 1993. MMWR 1994; 42: 1-75.
10. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-1 staphylococci, Lancet 1978; 2: 1.116-1.118.
11. David JP, Chesney PJ, Waud PJ, LaVenture M. The investigation and laboratory team. Toxic-shock syndrome. Epidemiologic features, recurrence, risk factors and prevention. N Engl J Med 1980; 303: 1.429-1.435.
12. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hargrett NT et al. Toxic-shock syndrome in menstruating women. Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 1980; 303: 1.436-1.442.
13. Broome CU, Hayes PS, Ajello GW, Feeley JC, Gibson RJ, Graves LM et al. In vitro studies of interactions between tampons and Staphylococcus aureus. Ann Intern Med 1982; 96: 959-962.
14. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fam PT, Wolf RA et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 1981; 305: 1.425-1.431.
15. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, Holzman RS et al. An outbreak of community acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1.431-1.438.
16. UNAIDS. HIV/AIDS situation december 1996 (15 pp). http://www.unaids.org/highband/document epidemio/situat 96.html.
17. WHO. Report of WHO meeting on emerging infections diseases. Ginebra: CDS/BVI/92.2, 25-26 de abril de 1994.
18. Domínguez Carmona M. La nueva patología infecciosa. Madrid: Anales de la Real Academia Nacional de Medicina, 1987; 365-394.
19. Ampel NM. Plagues-what's past is present: thoughts on the origin and history of new infectious diseases. Rev Infect Dis 1991; 13: 658-665.
20. Morse SS. Emerging viruses. Oxford: Oxford University Press, 1983.
21. institute of Medicine. Emerging infections. Microbial threats to health in the United States. Washington DC: Nacional Academy Press, 1992.
22. Gestal Otero JJ. Enfermidades infecciosas emerxentes. A Corun̄a: Real Academia de Medicina e Cirurxia de Galicia, 1995; 109 pp.
23. McMacken M, Castro KG. La tuberculosis y el virus de la inmunodeficiencia humana en los Estados Unidos, 1985-1992. Bol Oficina Sanit Panam 1994; 117: 77-83.
24. WHO. Cholera in 1991. WER 1992; 67: 253-260.
25. WHO. Plague. India. WER 1994; 69: 289-291.
26. CDC. Addressing emerging infectious diseases threats. US Department of Health and Human Services. Public Health Service. Georgia: CDC Atlanta, 1994.
27. Piedrola Angulo G. Nuevas perspectivas en enfermedades transmisibles. Madrid: Anales de la Real Academia Nacional de Medicina, 1993; 459-472.
28. Relman DA, Loutit JS, Schmidt JM, Falkow S, Tompkins LS. The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens. N Engl J Med 1990; 323: 1.573-1.580.
29. Koehler JE, Quinn F, Berger TG, LeBoit PE, Tappero JW. Isolation of rochalimae species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med 1992; 328: 1.422-1.423.
30. Dawson JE, Anderson BE, Fishbein DB, Sánchez J, Goldsmith CS, Wilson KH et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. Clin Microbiol 1991; 29: 2.741-2.745.
31. CDC. update: multistate outbreak of Escherichia coli 0157:H7 infections from hamburgers-Western United States 1992-1993. MMWR 1993; 42: 258-263.
32. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic E. coli and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-80.
33. CDC. Outbreak of acute illness -southwestern United States, 1993. MMWR 1993; 42: 421-424.
34. Elliott LH, Ksiazek TG, Rollin PE, Spiropoulou CF, Morzunov S, Monroe M et al. Isolation of the causative agent of hantavirus pulmonar syndrome. Am J Trop Med Hyg 1994; 51: 102-108.
35. Feldmann H, Sánchez A, Morzunov S, Spiropoulou CF, Rollin PE, Ksiazek TG Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res 1993; 30: 351-367.
36. Yanagihara R. Hantavirus infection in the United States: epizootiology and epidemiology. Rev Infect Dis 1990; 12: 449-457.
37. LeDuc J, Childs JE, Glass GE, Watson AJ. Hantaan (Korean hemorrhagic fever) and related rodent zoonoses. En: Morse SS, editor. Emerging viruses. New York: Oxford University Press, 1993; 149-158.
38. Okello GBA, Agata N, Ouma J, Cherogony SC, Tukei PM, Ochieng W et al. Outbreak of yellowfever in Kenya. Lancet 1993; 341: 489.
39. Streatfield R, Bielby G, Sinclair D, A primary dengue 2 epidemic with spontaneous haemorraghic manifestations. Lancet 1993; 342: 560-561.
40. CDC. Re-emergence of Bolivian haemorrhagic fever. Bolivia WER 1995; 70: 16-17.
41. Bennett D, Brown D. Ebola virus. Poor countries may lack the resources to prevent or minimise transmission. Br Med J 1995; 310: 1.344.
42. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Sciencie 1992; 257: 1.055-1.063.
43. Porter JDH, McAdam KPWJ. The re-emergence of tuberculosis. Annu Rev Public Health 1994; 15: 303-323.
44. Styblo K. The impact of HIV infection on the global epidemiology of tuberculosis. Bull Int Union Tuberc Lung Dis 1991; 66: 27-32.
45. Braun MM, Truman BI, Maguire B, DiFerdinando GT Jr, Wormser G, Broaddus R et al. Increasing incidence of tuberculosis in a prison inmate population: association with HIV infection. JAMA 1989; 261: 393-397.
46. Edlin BR, Tokars J, Griego MH, Crawford JT, Williams J, Sordillo. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326: 1.514-1.521.
47. CDC. Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital-Florida. MMWR 1990; 39: 718-722.
48. CDC. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons -Florida and New York, 1988-1991. MMWR 1991; 40: 581-591.
49. CDC. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility, Michigan. MMWR 1991; 40: 129-131.
50. Beck Sagué C, Dooley SW, Hutton MD, Sosin DM, Beckett GA, Houck-Jankoski A et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. JAMA 1992; 268: 1.280-1.286.
51. Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullán JV et al. Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA 1992; 267: 2.632-2.635.
52. Fischl MA, Uttamchandani RB, Daikos GL, Poblete RB, Moreno J, Reyes R et al. An outbreak of tuberculosis caused by multiple-drug resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 1992; 117: 177-183.
53. Pearson ML, Jereb JA, Frieden TR, Crawford JT, Davis BJ, Dooley SW et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992; 117: 191-196.
54. Haley CE, McDonald RC, Rossi L, Jones WD Jr, Haley RW, Luby JP. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989; 10: 204-210.
55. Communicable Disease Report. Outbreak of hospital acquired multidrug resistance tuberculosis. United Kingdom. Weekly: PHLS Communicable Disease Surveillance Centre, 1995.
56. Rullán JV, Herrera D, Cano R, Moreno V, Godoy P, Peiró EF et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerging Inf Dis 1996; 2: 125-129.
57. CDC. Tuberculosis. Secular trends of tuberculosis in Western Europe. WER 1993; 68: 65-72.
58. WHO. Tuberculosis trends in Central and Eastern Europe and countries of the former USSR. WER 1995; 70: 21-24.
59. WHO. Cholera in 1990. WER 1991; 66: 133-137.
60. WHO. Cholera in 1991. WER 1992; 67: 253-260.
61. WHO. Cholera in 1992. WER 1993; 68: 149-155.
62. WHO. Cholera in 1993. Part 1. WER 1994; 69: 205-212.
63. WHO. Cholera in Europe. WER 1994; 69: 322-323.
64. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T et al. Emergence of a novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993; 341: 703-704.
65. Albert MJ, Siddique AK, Islam M, Faruque AS, Ansaruzzaman M, Faruque SM et al. Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh. Lancet 1993; 341: 704.
66. International Centre for Diarrhoeal Diseases Research, Bangladesh. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio Cholerae 0139 Bengal. Lancet 1993; 342: 387-390.
67. Fisher-Hoch SP, Khan A, Inam-ul-Haq, Atakhan M, Mintz ED. Vibrio cholerae 0139 in Karachi. Pakistan. Lancet 1993; 342: 1.422-1.423.
68. WHO. Epidemic diarrhea due to Vibrio cholerae non-01. WER 1993; 68: 141-148.
69. OPS. Una cepa nueva de vibrión colérico con potencial epidémico. Bol Oficina Sanit Panam 1994; 117: 182-184.
70. Preston NW Cholera isolates in relation to the «eight pandemic». Lancet 1993; 342: 925-926.
71. WHO. Cholera. Update, end of 1993. WER 1993; 69: 13-17.
72. WHO. Plague. India. WER 1994; 69: 289-291.
73. WHO. Plague. India. WER 1994; 69: 295-299.
74. WHO. Plague. Update India. WER 1994; 69: 302-303.
75. WHO. Plague. International team of experts. India. WER 1994; 69: 321-322.
76. WHO. Expanded Programme on Immunization Outbreak of diphtheria. USRR. WER 1991; 66: 181-185.
77. WHO. Expanded Programme on Immunization. Diphtheria epidemic. Ukraine. WER 1994; 69: 253-258.
78. WHO Expanded Programme on Immunization. Diphtheria outbreak. Belarus WER 1994; 69: 349-352.
79. WHO Expanded Programme on Immunization, Outbreak of diphtheria, update. Russian Federation. WER 1993; 68: 134-138.
80. CDC. Diphtheria epidemic -New Independent States of the former Soviet Union, 1990-1994. MMWR 1995; 44: 177-181.
81. WHO. Expanded Programme on Immunization. Recrudescence of diphtheria. Poland. WER 1993; 68: 261-264.
82. WHO. Expanded Programme on Immunization. Certification of poliomyelitis eradication -The Americas, 1994. WER 1994; 69: 293-295.
83. WHO. Expanded Programme on Immunization. Poliomyelitis outbreak. Bulgaria. WER 1992; 67: 336-337.
84. WHO. Expanded Programme on Immunization. Poliomyelitis outbreak. Netherlands. WER 1992; 67: 341-344.
85. WHO. Poliomyelitis outbreak. Albania. WER 1996; 71: 293-295.
86. WHO. Expanded Programme on Immunization. Progress towards the global eradication of poliomyelitis, 1995. WER 1996; 71: 189-194.
87. OMS. Erradicación de la poliomielitis. Informe de la Primera Reunion de la Comisión Regional Europea de Certificación de la Erradicación de la Poliomielitis (Paris 7-8 de marzo de 1996). Copenhague: Oficina Regional Europea de la OMS, 1996; 25 pp.
88. Anónimo. Invasive group A streptococcal infections in Gloucestershire. Commun Dis Rep 1994; 4: 97.
89. Meleney FL. Hemolytic streptococcus gangrene. Arch Surg 1924; 9: 317-364.
90. Graham D4. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-625.
91. Wyatt JI, Dixon MF. Chronic gastritis -a pathogenetic approach. J Pathol 1988; 154: 113-124.
92. Parsonnet, Friedman G, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1.127-1.131.
93. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1.043-1.048.
94. Murray DM. Clinical relevance of infection by Helicobacter pylori. Clin Microbiol Newsletter 1993; 15: 33-36.
95. Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital papillomaviruses and cervical cancer. Rev Infect Dis 1989; 11: 426-439.
96. Alter MJ, Margolis HS, Krawczynkis K, Judson FN, Mares A, Alexander WJ et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992; 321: 1.899-1.905.
97. Bruguera M. La hepatitis C, otra plaga. Med Clin (Barc) 1994; 103: 615-616.
98. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470.
99. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1.490-1.495.
100. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993; 1: 788-789.
101. Kuo C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JTI. Demonstration of Chlamydia pneumonias in at herosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
102. Glass GE, Watson AJ, LeDuc JW, Kelen GD, Quinn TC, Childs JE. Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 1993; 167: 614-620.
103. Gentilini M, Danis M. Le paludisme autochtone. Med Mal Infect 1981; 11: 356-362.
104. Rupp ME, Archer GL. Coagulase-negative staphylococci: pathogenes associated with medical progress. Clin Infect Dis 1994; 19: 231-245.
105. Lyerly DM. Epidemiology of Clostridium difficile disease. Clin Microbiol Newsletter 1993; 15: 49-52.
106. WHO. Cholera in Europe. WER 1994; 69: 322-323.
107. o RR-13): 1-132.
108. Cameron AS, Beers MY, Walker CC, Rose N, Ancar E, Manatakis Z et al. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli 0111: NM. South Australia, 1995. MMWR 1995; 44: 550-551, 557-558.
109. Moore K, Damrow T, Abbott DO, Jankonski S. Outbreak of acute gastroenteritis attributable to Escherichia coli serotype 0104:H21-Helena, Montana, 1994. MMWR 1995; 44: 501-503.
110. WHO. Cryptosporidiosis. Cryptosporidium in water supplies. WER 1990; 65: 367-368.
111. Grant IH, Gold JWM, Wittner M, Tanowitz HB, Nathan C, Mayer K et al. Transfussion associated acute Chagas disease acquired in the United States. Ann Intern Med 1989; 111: 849-851.
112. Nickerson P, Or P, Schroeder ML, Sekla L, Johnson JB. Transfussion associated Trypanosoma cruzi infection in a non-endemic area. Ann intern Med 1989; 111: 851-853.
113. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992 and 1993. Clin Infect Dis 1994; 19 (Supl 1): 14-18.
114. Siegert R, Shu HL, Slenczka W, Peters D, Muller G. Zur Atiologie einer Umbekanrten, von Aften ausgegangenen menschlichen Infektions-krankhett. Dtsch Med Wochenschr 1967; 92: 2.341-2.343.
115. WHO. Viral hemorrhagic fever in importtet monkeys. Wkly Epidemiol Rec 1992; 67: 142.
116. Pearson S, Cottingham M, Pueak G, Hendricks K, Taylor J, Fearnyhough G et al. Ebola-Reston virus infection amoung quarantined non-human primates. MMWR 1996; 45: 314-315.
117. Institute of Medicine. Emerging infections. Microbial threats to health in the United States. Washington DC: Nacional Academy Press, 1992.
118. Institute of Medicine. The US capacity to address tropical infectious disease problems. Washington DC: Nacional Academy Press, 1987.
119. Institute of Medicine. The future of Public Health. Washington DC: Nacional Academy Press, 1988.
120. CDC. Addressing emerging infectious disease threats. US Georgia: Department of Health and Human Services. Public Health Service. CDC Atlanta, 1994.
121. Ledeberg J. Medical science infectious disease, and the unity of humankind. JAMA 1988; 260: 684-685.
122. WHO. Report of WHO meeting on emerging infections diseases. Ginebra: CDS/BVI/92.2, 25-26 de abril de 1994.
123. Real Decreto 2210/1995, de 28 de diciembre. BOE, 24 de enero de 1996.
124. WHO. Emerging Infectious Diseases. World Health Day 1997. Global alert, global response. Ginebra: WHO, 1997; 40 pp.
125. o 12 1997; 137 pp.